The FDA must approve intranasal treatments for anaphylaxis

Millions of people, including children, suffer from life-threatening food allergies in the U.S. The most common treatment is an injectable epinephrine needle, but many people do not have access to or feel comfortable using it. There are alternatives, such as sublingual and intranasal epinephrine, but they are not widely available. Lawmakers and regulators need to approve these treatments for those who need them, as it could save lives. The lack of progress in this area is frustrating for those with allergies and their families. Approval of these alternatives is crucial, as it is not just a “good to have” but a “must have” for patients and their families.

Source link